4.8 Review

Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer

Journal

IMMUNITY
Volume 50, Issue 2, Pages 302-316

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2019.01.020

Keywords

-

Categories

Funding

  1. Japan Society for Promotion of Science (JSPS) [16H06295, 18K07175]
  2. JSPS [16H06295, 17K15723]
  3. Project for Cancer Research and Therapeutic Evolution by Japan Agency for Medical Research and Development [P-CREATE: JP18cm0106303]
  4. Leading Advanced Projects for medical innovation by Japan Agency for Medical Research and Development [LEAP: JP18gm0010005]
  5. Grants-in-Aid for Scientific Research [16H06295, 18K07175, 17K15723] Funding Source: KAKEN

Ask authors/readers for more resources

Regulatory T (Treg) cells expressing the transcription factor Foxp3 have a critical role in the maintenance of immune homeostasis and prevention of autoimmunity. Recent advances in single cell analyses have revealed a range of Treg cell activation and differentiation states in different human pathologies. Here we review recent progress in the understanding of human Treg cell heterogeneity and function. We discuss these findings within the context of concepts in Treg cell development and function derived from preclinical models and insight from approaches targeting Treg cells in clinical settings. Distinguishing functional Treg cells from other T cells and understanding the context-dependent function(s) of different Treg subsets will be crucial to the development of strategies toward the selective therapeutic manipulation of Treg cells in autoimmunity and cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available